Range Resources (NYSE:RRC) reported quarterly earnings of $1.37 per share which met the analyst consensus estimate. This is a 163.46 percent increase over earnings of $0.52 per share from the same period last year.
Oppenheimer Maintains Outperform on Alnylam Pharmaceuticals, Raises Price Target to $256
Oppenheimer analyst Leland Gershell maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the price target from $170 to $256.
